Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat-Reference-Cited by-同舟云学术

Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat

Published:2017-05-31 Issue:5 Volume:14 Page:423-433
ISSN:1479-1641
Container-title:Diabetes and Vascular Disease Research
language:en
Short-container-title:Diabetes and Vascular Disease Research

Author:

Tate Mitchel¹,Deo Minh¹,Cao Anh H¹²,Hood Sally G³,Huynh Karina¹,Kiriazis Helen⁴,Du Xiao-Jun⁴,Julius Tracey L¹,Figtree Gemma A⁵,Dusting Gregory J⁶,Kaye David M⁷⁸,Ritchie Rebecca H¹⁸

Affiliation:

1. Heart Failure Pharmacology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, VIC, Australia

2. Centre for Inflammatory Diseases, Monash University and Monash Medical Centre, Clayton, VIC, Australia

3. The Florey Institute of Neuroscience & Mental Health, University of Melbourne, Parkville, VIC, Australia

4. Experimental Cardiology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, VIC, Australia

5. North Shore Heart Research Group, Kolling Institute, University of Sydney, Sydney, NSW, Australia

6. Centre for Eye Research Australia, University of Melbourne, East Melbourne, VIC, Australia

7. Heart Failure Research Group, Baker IDI Heart & Diabetes Institute, Melbourne, VIC, Australia

8. Department of Medicine, Monash University, Clayton, VIC, Australia

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1479164117710390

Reference46 articles.

1. Global estimates of the prevalence of diabetes for 2010 and 2030

2. Global and societal implications of the diabetes epidemic

3. Role of diabetes in congestive heart failure: The Framingham study

4. Diabetes and cardiovascular risk factors: the Framingham study.

5. New type of cardiomyopathy associated with diabetic glomerulosclerosis

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermedin Alleviates Diabetic Cardiomyopathy by Up-Regulating CPT-1β through Activation of the Phosphatidyl Inositol 3 Kinase/Protein Kinase B Signaling Pathway;Pharmaceuticals;2024-09-12

2. Determining the Time Points for the Development of Early and Advanced Stages of Diabetic Cardiomyopathy in Streptozotocin-Induced Type 1 Diabetes Mellitus Rat Model;Sains Malaysiana;2024-06-30

3. High sugar diet–induced fatty acid oxidation potentiates cytokine-dependent cardiac ECM remodeling;Journal of Cell Biology;2024-06-25

4. Pharmacological Treatment of Diabetes Mellitus: An Overview of New Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Diabetes Mellitus;Journal of Endocrinology and Metabolism;2024-06

5. Insulin Treatment Does Not Prevent EARLY Autonomic Cardiovascular and Diastolic Dysfunctions in Streptozotocin-Induced Diabetic Rats;Pharmaceuticals;2024-04-30